Skip to main content
68th Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Red Recording
Sig Meeting
Sig Meeting

Therapeutics (NON-Industry)

(T 46) Efficacy and safety of rimegepant in the acute treatment of migraine among Chinese adults: real-world evidence from a multicenter, prospective, observational study

    Presenting Author(s)

  • YR

    Ye Ran, MD PhD

    Attending physician
    Department of Neurology, Chinese PLA General Hospital, Beijing, China;International Headache Centre, Chinese PLA General Hospital, Beijing, China
    Beijing, United States

    • Non-presenting Author(s)

  • QZ

    Qian Zhao, M.M.

    Pfizer Inc, Chengdu, China
    Chengdu, Sichuan, China (People's Republic)

  • HS

    Hui Su, M.D., Ph.D.

    Department of Neurology, Chinese PLA General Hospital, Beijing, China;International Headache Centre, Chinese PLA General Hospital, Beijing, China
    Beijing, Beijing, China (People's Republic)

  • SZ

    Shuhua Zhang, M.D.

    Department of Neurology, Chinese PLA General Hospital, Beijing, China;International Headache Centre, Chinese PLA General Hospital, Beijing, China
    Beijing, Beijing, China (People's Republic)

  • ZH

    Zizi He, M.D.

    Department of Neurology, Chinese PLA General Hospital, Beijing, China;International Headache Centre, Chinese PLA General Hospital, Beijing, China
    Beijing, Beijing, China (People's Republic)

  • YL

    Yu Liu, M.M.

    Pfizer Inc, Beijing, China
    Beijing, Beijing, China (People's Republic)

  • ZD

    Zhao Dong, M.D., Ph.D.

    Department of Neurology, Chinese PLA General Hospital, Beijing, China;International Headache Centre, Chinese PLA General Hospital, Beijing, China
    Beijing, Beijing, China (People's Republic)

  • SY

    Shengyuan Yu, n/a

    Director
    Chinese PLA General Hospital, Beijing, China
    Beijing, Beijing, United States